Skip Ribbon Commands
Skip to main content

​​​​​​​The Heart Hospital Baylor Plano Performs First Robotic-Assisted Angioplasty in DFW

Patients with coronary artery disease can now be treated with new robotic-assisted technology


​​January 19, 2017 – Baylor Scott & White The Heart Hospital – Plano today announced the successful completion of the first robotic-assisted coronary angioplasty in the Dallas-Fort Worth region. The procedure has been performed using Corindus Vascular Robotics CorPath System​—the first and only FDA-cleared medical device to bring robotic-assisted precision to coronary angioplasty procedures.

“Combining the enhanced visualization of the X-ray images with robotic precision will transform the way we perform angioplasty procedures and should ultimately improve patient care,” said Srinivas Potluri, medical director of the cardiac catheterization laboratory at Baylor Scott & White Heart – Plano​.

Coronary artery disease (CAD), characterized by plaque buildup that restricts blood flow in the arteries, is a widespread and life-threatening condition. It is the most common form of heart disease and the leading cause of death in America.

“An aging baby boomer population is driving demand for new, innovative technologies to treat CAD,” added Dr. Potluri. “Vascular robotics offers physicians and patients a minimally invasive technology that improves the precision of stent and balloon placements and reduces radiation exposure during the procedure for physicians.”

Traditionally, percutaneous coronary intervention (PCI), commonly known as an angioplasty, is the most common treatment for CAD. During this procedure, a balloon is used to physically open an artery blockage and help improve blood flow. During an angioplasty, interventional cardiologists often use stents, or wire metal mesh tubes, to prop open the artery and keep it open following the procedure. While angioplasty procedures remain one of the most frequently performed procedures in the United States, with over 900,000 cases annually, the procedure itself has remained largely unchanged for decades.

“We are proud to be the first medical center in DFW to launch a CorPath Vascular Robotic Program,” said Mark Valentine, president of Baylor Scott & White Heart – Plano. “The adoption of the CorPath System at Baylor Scott & White Heart – Plano truly emphasizes our continuous commitment to delivering advanced, innovative technology to our patients and clinical community.”​​